April 14, 2021
Intellectual Property Magazine
The U.S. Court of Appeals for the Fourth Circuit ruled in favor of Finnegan client Combe in another trademark dispute over the VAGISIL trademark. The court ruled that Dr. August Wolff’s VAGISAN mark for feminine healthcare products would cause consumer confusion with Combe’s VAGISIL mark, which has proven its strength as a leader in the feminine-care product space for several decades. Wolff argued that the district court erred in finding that ‘Vagisil’ and ‘Vagisan’ are “sufficiently similar,” but the appeals court disagreed.
Doug Rettew, Anna Naydonov, and Sydney English represented Combe in the district court case and the appeal. They said, “This marks another milestone for the client’s enforcement efforts and comes on the heels of a separate recent trial victory before the Trademark Trial and Appeal Board, where VAGISERT was refused as confusingly similar to Combe’s Vagisil and Vagistat marks.”
Read “Personal-Care Company Combe Victorious in Trademark Appeal”
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Award/Ranking
Managing IP Americas Awards 2024: Finnegan Shortlisted for Nine Awards, Including Firm of the Year
March 12, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.